STAR — Strides Pharma Science Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual income statement for Strides Pharma Science, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	R2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	30,703	36,884	38,901	45,653	48,587
Cost of Revenue
Gross Profit	13,672	18,567	19,314	23,733	29,000
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	36,071	35,615	37,183	39,935	41,626
Operating Profit	-5,368	1,269	1,719	5,719	6,960
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-6,525	-2,862	-1,148	4,869	6,687
Provision for Income Taxes
Net Income After Taxes	-4,743	-2,309	-1,439	4,094	5,745
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-4,602	-2,026	-706	35,935	5,562
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-4,602	-2,026	-706	35,935	5,562
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-30.4	-23.6	0.192	47.1	62.8
Dividends per Share